SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 138 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $123,000 | -53.2% | 26,289 | -34.3% | 0.02% | -51.1% |
| Q2 2016 | $263,000 | +198.9% | 40,012 | +173.5% | 0.05% | +213.3% |
| Q4 2015 | $88,000 | -13.7% | 14,631 | -13.8% | 0.02% | -28.6% |
| Q3 2015 | $102,000 | +5.2% | 16,974 | +19.6% | 0.02% | +10.5% |
| Q2 2015 | $97,000 | -27.1% | 14,197 | -25.9% | 0.02% | -48.6% |
| Q4 2014 | $133,000 | – | 19,152 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
| ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
| NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
| Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
| Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
| Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
| J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
| J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
| Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |